title: Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16.
abstract: Generally, cancers may undergo the developmental stages of benign proliferation, precancer and invasive cancer. Identification of biomarkers that are expressed throughout the developmental stages will facilitate detection, prevention and therapy of cancer. Piwil2, a member of AGO/PIWI family of proteins, has been suggested to be associated with tumor development. Here we reported that piwil2 can be detected by immunohistochemistry (IHC) in various stages of human cervical squamous cell carcinomas and adenocarcinomas. Interestingly, piwil2 was also detected in some metaplastic epithelial cells as well as histologically "normal" appearing tissues adjacent to malignant lesions. While all the premalignant and malignant lesions expressed varying levels of piwil2, p16(INK4a) (p16), a surrogate indicator of high-risk human papillomavirus (HR-HPV) infection, was detected in only 84.62% of the specimens. In Papanicolaou (Pap) test, piwil2 was also detected in atypical glandular cells (AGC), low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL), whereas p16 was not always concomitantly detected in the same specimens. The results suggest that piwil2 might play important roles throughout the process of cervical cancer development and have the potential to be used as a complementary marker for p16(INK4a). It is worth further study to improve the sensitivity and specificity of current screening methods for cervical cancers.
authors.forename: Gang
authors.initials: G
authors.lastname: He
authors.forename: Li
authors.initials: L
authors.lastname: Chen
authors.forename: Yin
authors.initials: Y
authors.lastname: Ye
authors.forename: Yi
authors.initials: Y
authors.lastname: Xiao
authors.forename: Keding
authors.initials: K
authors.lastname: Hua
authors.forename: David
authors.initials: D
authors.lastname: Jarjoura
authors.forename: Toru
authors.initials: T
authors.lastname: Nakano
authors.forename: Sanford H
authors.initials: SH
authors.lastname: Barsky
authors.forename: Rulong
authors.initials: R
authors.lastname: Shen
authors.forename: Jian-Xin
authors.initials: JX
authors.lastname: Gao
references.citation: Science. 2007 May 4;316(5825):744-7
references.pmid: 17446352
references.citation: Genomics. 2003 Sep;82(3):323-30
references.pmid: 12906857
references.citation: Int J Clin Exp Pathol. 2010 Mar 20;3(4):328-37
references.pmid: 20490325
references.citation: Cell. 2006 Jun 2;125(5):873-86
references.pmid: 16751098
references.citation: Cell. 2007 Mar 23;128(6):1089-103
references.pmid: 17346786
references.citation: Cancer Detect Prev. 2006;30(5):387-94
references.pmid: 17079091
references.citation: Clin Cancer Res. 2006 Nov 15;12(22):6626-36
references.pmid: 17121881
references.citation: Clin Cancer Res. 2005 Jan 1;11(1):166-72
references.pmid: 15671542
references.citation: Int J Clin Exp Pathol. 2009;2(1):21-33
references.pmid: 18830381
references.citation: Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):989-95
references.pmid: 16467114
references.citation: Curr Biol. 2009 Apr 28;19(8):640-4
references.pmid: 19345100
references.citation: Hum Mol Genet. 2006 Jan 15;15(2):201-11
references.pmid: 16377660
references.citation: Cancer. 2005 Dec 25;105(6):457-60
references.pmid: 16104044
references.citation: MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
references.pmid: 17380109
references.citation: J Cell Mol Med. 2008 Jan-Feb;12(1):67-96
references.pmid: 18053092
references.citation: PLoS One. 2008 Feb 20;3(2):e1652
references.pmid: 18286204
references.citation: PLoS One. 2009;4(2):e4544
references.pmid: 19229342
references.citation: J Immunol. 2003 Jun 15;170(12):5927-35
references.pmid: 12794119
references.citation: Nature. 2006 Jul 13;442(7099):203-7
references.pmid: 16751777
references.citation: Genes Dev. 2006 Jul 1;20(13):1709-14
references.pmid: 16766680
references.citation: Nat Med. 2004 Aug;10(8):789-99
references.pmid: 15286780
references.citation: J Biol Chem. 2009 Mar 6;284(10):6507-19
references.pmid: 19114715
references.citation: Clin Gastroenterol Hepatol. 2004 Jan;2(1):1-8
references.pmid: 15017625
references.citation: Lancet. 2007 Sep 8;370(9590):890-907
references.pmid: 17826171
references.citation: Mol Reprod Dev. 2006 Feb;73(2):173-9
references.pmid: 16261612
references.citation: Genes Dev. 2006 Aug 15;20(16):2214-22
references.pmid: 16882972
references.citation: JAMA. 2002 Apr 24;287(16):2120-9
references.pmid: 11966387
references.citation: N Engl J Med. 1998 Feb 12;338(7):423-8
references.pmid: 9459645
references.citation: Science. 2006 Jul 21;313(5785):363-7
references.pmid: 16778019
references.citation: Am J Pathol. 1998 Dec;153(6):1741-8
references.pmid: 9846965
references.citation: Genes Dev. 2002 Nov 1;16(21):2733-42
references.pmid: 12414724
references.citation: Nature. 2009 Apr 9;458(7239):719-24
references.pmid: 19360079
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):295-301
references.pmid: 17301262
references.citation: Int J Gynecol Pathol. 2009 Jan;28(1):90-7
references.pmid: 19047902
references.citation: Annu Rev Cell Dev Biol. 2009;25:355-76
references.pmid: 19575643
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13415-20
references.pmid: 16938833
references.citation: Nature. 2007 Nov 8;450(7167):304-8
references.pmid: 17952056
references.citation: Cancer Cell Int. 2007 Mar 15;7:2
references.pmid: 17362521
references.citation: Cancer Lett. 1999 Feb 8;136(1):101-8
references.pmid: 10211947
references.citation: PLoS One. 2007 Mar 14;2(3):e293
references.pmid: 17356702
references.citation: Cancer. 2006 Dec 25;108(6):451-61
references.pmid: 17078096
references.citation: Oncogene. 2002 Jun 6;21(25):3988-99
references.pmid: 12037681
references.citation: Development. 2004 Feb;131(4):839-49
references.pmid: 14736746
references.citation: BMC Cancer. 2004 Jul 19;4:37
references.pmid: 15257755
references.citation: Science. 2004 Sep 3;305(5689):1437-41
references.pmid: 15284456
references.citation: Trends Mol Med. 2008 Aug;14(8):323-32
references.pmid: 18635398
references.citation: Cancer Treat Rev. 2009 May;35(3):210-20
references.pmid: 19261387
references.citation: J Cell Physiol. 2000 Mar;182(3):311-22
references.pmid: 10653597
references.citation: Mech Dev. 2001 Oct;108(1-2):121-33
references.pmid: 11578866
references.citation: Genes Dev. 1998 Dec 1;12(23):3715-27
references.pmid: 9851978
references.citation: J Natl Cancer Inst. 2005 Sep 21;97(18):1317-9
references.pmid: 16174847
references.citation: J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8
references.pmid: 16174854